
- Home
- Top Stories
- Patent Filings in India Surge—Are... authors
Patent Filings in India Surge—Are Universities Faking Innovation?
Patent filings in India are soaring, especially in private universities, but low grant rates reveal a hollow “innovation boom” built on volume, not value.

- 1.0x
- 1.25x
- 1.5x
- 2.0x
Patent Filings in India Are Rising Fast—but Are Universities Cutting Corners?
India today looks, on paper, like a country in the middle of an intellectual property renaissance. Patent filings in India are rising, universities are boasting of innovation, and private institutions, in particular, are flaunting filing numbers that would make even older public institutions pause. Yet, the closer one looks, the more this glitter begins to peel.
Support Independent Journalism Public interest stories that affect ordinary citizens — especially those without power or voice — requires time, resources, and independence. Your support — even a modest contribution — allows us to uncover stories that would otherwise remain hidden. Support The Probe by contributing to projects that resonate with you (Click Here), or Become a Member of The Probe to stand with us (Click Here). |
The latest parliamentary data has exposed a deeply uncomfortable truth: private universities patents are being filed in astonishing volumes, but their record in actually securing patent grants remains distressingly poor. That mismatch between filing and grant is not a minor procedural curiosity. It opens up troubling questions about the quality of research, the misuse of policy incentives, the distortions created by university ranking systems, and the wider tendency in India to confuse statistical activity with genuine innovation.
Also Read: UGC Fails to Act as Fake Universities Thrive
The real scandal is not merely that too many weak patents may be getting filed. It is that India may be rewarding the performance of innovation rather than innovation itself. This narrative seeks to examine the background to the filing boom, the incentives driving private institutions to pile up patent applications, the reasons why grant rates remain weak, whether public money or public policy is being gamed, how India compares with the United States, the United Kingdom, Europe, Australia, Japan, Singapore, and China, and why the ultimate question is not who files more patents, but who turns knowledge into useful products, processes, enterprises, and economic value.
Patent Filings in India vs Grants: The Hidden Reality Behind University Patents
In FY 2024–25, according to data tabled in Parliament and widely reported on 17 March 2026, the top 50 private institutions filed 19,540 patent applications, while the top 50 government institutions filed only 615. At first glance, that sounds like a revolution in private sector innovation. It suggests an educational landscape in which private universities are bursting with invention while government institutions are plodding along. But the glamour vanishes the moment one turns to actual grants.
The same data showed that private institutions received 399 patents, while government institutions received 193. The filing ratio was roughly thirty-two to one; the grant ratio was barely two to one. That is not merely a gap. That is a collapse. It means that the enormous lead in applications is not translating into anything remotely similar in legally validated intellectual property. On the implied figures, the private cohort’s grant rate was about 2 percent, while the government cohort’s rate was roughly 31 percent. That comparison alone is enough to puncture the inflated rhetoric that usually surrounds university patent counts in India.
Patent Filings in India | The Hidden Reality Behind University Patents | Graph: The Probe Team
This is where the debate becomes more serious than a mere comparison of statistics. A low grant rate does not automatically prove wrongdoing. Patent examination is technical, time-consuming, and necessarily selective. Applications may be pending, objections may be unresolved, and grants in a given year may relate to filings from much earlier years.
The government itself has correctly noted that patents move through an examination pipeline, and grants are not a same-year reflection of filings. But even after allowing for that lag, the pattern remains too stark to ignore. When one group files tens of thousands of applications but secures only a thin trickle of grants, the obvious question is whether the system is rewarding bulk filing rather than defensible invention. That is where the Indian debate has now arrived.
The roots of this boom lie in policies that were, in their original conception, sensible and even progressive.
In September 2021, the Government of India extended to educational institutions an 80 percent reduction in patent filing and prosecution fees. The logic was sound: if universities and research institutions are expected to contribute to a knowledge economy, they should not be deterred by high filing costs. The reform was sold as a way to encourage greater participation of academia in the patent ecosystem, and in principle, it was hard to quarrel with that objective. The state wanted to lower barriers and spread awareness. It also expanded policy support through awareness drives such as the National Intellectual Property Awareness Mission. On paper, it looked like a classic reform in the service of Atmanirbhar Bharat and a knowledge-based economy.
But reforms, particularly in India, do not operate in a vacuum. They collide with rankings, vanity metrics, institutional competition, faculty career incentives, state reimbursement schemes, internal appraisal systems, and aggressive publicity departments.
Once patent filings in India became cheap, it did not remain merely a legal process. It became a performance metric. It became a branding device. It became a way to signal “innovation” to regulators, ranking agencies, parents, students, investors, and accreditation bodies. In that transformation lies the heart of the present problem. A patent application is no longer just an attempt to secure legal protection for a potentially valuable invention. In many institutions, it has become a badge to be counted, displayed, and marketed long before it has survived substantive scrutiny.
Also Read: CAG Audits, Corruption, 2G & Coalgate: Why “Scams” Fail in Court
Patent Filings in India: How University Patents Became a Ranking Game
The National Institutional Ranking Framework has played no small part in this distortion. Under the NIRF framework, patent filings in India are not measured only through grants. Patents published also carry weight. The overall framework allocates marks for “Patents Published & Granted,” and the innovation framework goes even further by separately emphasising patents and technology transfer. In plain language, this means an institution can gain reputational benefit not only from inventions that the patent office has found worthy of protection, but also from applications that have merely entered the publication pipeline.
Since publication follows filing after the statutory period, institutions that file in volume can build a reputation for “innovation intensity” long before anyone knows whether the applications are novel, inventive, or industrially applicable. This is the quiet loophole at the centre of the drama. India did not simply encourage innovation. It created an ecosystem in which filing itself became a rewarded event.
That is why the present controversy should not be reduced to one sensational institutional example, even though the Galgotias episode gave it a human face. When public attention turned to Galgotias University after the embarrassing robotic-dog controversy at the India AI Impact Summit, scrutiny naturally expanded to its patent record. There, too, the numbers were startling: thousands of filings, but only a tiny proportion resulting in grants. Critics pointed out that some of the patents being filed appeared to be weak, poorly grounded, or unlikely to survive serious examination.
The point is not to single out one institution for public flogging. The larger problem is that Galgotias became a symbol of a structural reality: when the incentives reward the accumulation of applications rather than the production of durable inventions, outliers are bound to emerge.
The deeper issue, therefore, is not whether private universities are “filing too many” patents in some abstract moral sense. The deeper issue is why they are filing so many, and what these filings actually represent. There are several reasons. The first is reputational competition. The private higher education market in India is crowded, commercial, and intensely image-driven. In such an ecosystem, patent statistics can be advertised as proof of cutting-edge research, even if the actual quality of the applications is highly uneven.
The second reason is internal incentives. Faculty members in some institutions are nudged, coaxed, rewarded, or even pressured to generate patent applications because these become measurable outputs for appraisal systems, promotional dossiers, and annual reports. The third is ranking arithmetic. A university that can boost its patent publication numbers may gain ground in perception and evaluation, regardless of how many of those filings are later abandoned, refused, or quietly forgotten. The fourth is low cost. When official filing fees are heavily subsidised, the marginal cost of speculative filing falls sharply. The result is predictable: more people file weak applications because the downside is smaller and the visible upside is larger.
One must, however, proceed carefully when the conversation turns to “misuse of government grants.” That phrase can mean several different things. If it means whether there is conclusive evidence that private universities are illegally siphoning direct state funds merely by filing frivolous patents, the answer is: the public evidence is not yet sufficient to sustain such a sweeping accusation across the board.
The parliamentary response cited by the report did not confirm systematic misuse in those terms. It instead pointed to substantive examination safeguards and governance structures in publicly supported research programmes. That matters. One should not turn suspicion into accusation without hard evidence.
Yet that is not the end of the matter. There is a broader and more troubling form of misuse that does not always wear the crude face of fraud. It is the misuse of policy intent. A scheme designed to encourage genuine research can be gamed if institutions discover that the symbolic benefit of filing is immediate while the legal scrutiny is delayed. A ranking system intended to identify excellence can be manipulated if it rewards patent publications that have not yet faced the acid test of examination. An institutional grant or reimbursement framework can become distorted if paperwork-based indicators outrun quality-based validation. This is the area where India must be intellectually honest. Even if the legal case for “fraud” is not always clear, the case for incentive distortion is overwhelming. The system is producing exactly the kind of behaviour it was designed—perhaps unintentionally—to reward.
Also Read: IDFC First Bank Fraud: Inside the ₹590 Crore Shock
Patent Filings in India: Why Government University Patents Perform Better
What explains the much better performance of government institutions? The answer lies partly in research culture and partly in selection discipline. Institutions such as the IITs, IISc, and leading public research centres are far from flawless, but they generally file fewer applications and tend to do so in a more selective manner. Their research pipelines are often linked to stronger laboratories, longer research traditions, external peer engagement, and better-developed faculty ecosystems. Their patent applications are more likely to emerge from sustained research rather than annual target-chasing. That does not mean every government-filed patent is commercially significant, but it does mean the filing decision is often more filtered.
Public institutions, in other words, are more likely to treat patents as one result of research. Many private institutions seem, by contrast, to treat patents as a research substitute—or at least as a publicly marketable surrogate for it.
That distinction becomes even sharper when one turns from grant rates to the larger question of commercialisation. Here, India’s weakness becomes glaring. A patent is not a medal. It is not an educational decoration. It is not even, by itself, an economic asset in any meaningful sense. A patent becomes valuable when it is licensed, assigned, embedded in a product, used to attract investment, used to build a startup, or strategically deployed in a commercial negotiation. On that front, India remains weak across both public and private institutions. We talk loudly about the surge in patent filings in India but less about grants, and far too little about licensing, royalty streams, startup creation, technology transfer income, or industrial adoption. That silence is revealing. It suggests that the Indian university patents conversation is still stuck at the stage of counting documents rather than tracing outcomes.
From Patents to Products: Lessons from Global Innovation Leaders
This is where international comparisons become extraordinarily useful, because they show that the real strength of advanced innovation ecosystems lies not in filing, but in what follows filing. In the United States, the Bayh-Dole system transformed university technology transfer by allowing universities to retain title in federally funded inventions. But Bayh-Dole was never a magic wand. What made the American system formidable was the institutional machinery surrounding it: invention disclosure systems, technology transfer offices, licensing professionals, venture capital linkages, proof-of-concept funds, incubators, and startup pathways.
U.S. data cited by the National Science Board show that universities execute thousands of licenses and options and continue to produce a large stream of startups from academic research. AUTM’s licensing surveys likewise track disclosures, licenses, startup formation, and products on the market, not merely patents filed. The American lesson is not that patents automatically generate wealth. It is that patents are treated as one step in a commercial pipeline, not as the end of the journey.
The United Kingdom offers a similarly sobering lesson. Britain’s independent review of university spin-outs did not romanticise the system. It acknowledged quite bluntly that many universities do not make large profits from commercialisation and that technology transfer can be expensive and uneven. But what is striking is the maturity of the British conversation. The debate is not trapped in crude filing counts. It is about spin-out structures, founder equity, investor confidence, standard deal terms, patient capital, and pathways from campus science to market outcomes. A country becomes serious about university innovation when it stops asking, “How many patents did you file?” and starts asking, “How many technologies crossed the valley of death?” Britain may not have solved every problem, but it is asking the right question. India still too often asks the wrong one.
Europe, too, has steadily moved toward the concept of valorisation—the translation of research into social and economic value. European policy work on the management and commercialisation of intellectual property in universities emphasises proof-of-concept support, portfolio management, specialised technology transfer capacity, local industrial partnerships, and measurable exploitation of university inventions.
Reports supported by the European Commission note that a meaningful proportion of university inventions are commercially exploited, often with SMEs as important partners. That is a world away from the Indian spectacle of celebrating raw application counts without even a clear national dashboard showing how many university patents were ultimately licensed or revenue-generating.
Australia presents another variation on the same theme. The country’s policy institutions have repeatedly focused on research translation, university-industry collaboration, and pathways from publicly funded research to industry use. What matters in the Australian discourse is not simply academic patent activity, but research impact, translational support, and commercialisation capability. That emphasis reflects a realism India badly needs. Patents do not become economically valuable merely because a university website says they exist. They become valuable when firms trust them, investors fund them, regulators clear them, manufacturers use them, and markets adopt them.
Japan’s model is particularly instructive because of the seriousness with which it tracks technology transfer outcomes. The University Network for Innovation and Technology Transfer maintains surveys on disclosures, patent applications, licenses, TT office staffing, and related indicators. This reflects a discipline that India lacks.
Once a system begins measuring invention disclosures, license agreements, office capacity, and commercialisation outputs, the seduction of vanity filing becomes harder to sustain. Japan’s approach recognises that innovation is an institutional chain. Break the chain at the transfer stage, and the patent becomes an archive item.
Singapore’s approach is even more tightly engineered. Rather than assuming that patents will somehow walk out of laboratories and into factories by themselves, Singapore has built national platforms to connect university research with entrepreneurial teams, investors, and commercialisation support. Its GRIP-style model treats startup creation, translational mentoring, and market validation as integral to the innovation process. There is a clarity here that India would do well to study. Filing is not the climax. Filing is the beginning of a hard, uncertain, capital-intensive journey.
China offers perhaps the most cautionary and relevant comparison for India because it, too, passed through a period of patent number obsession. For years, Chinese institutions were criticised for chasing volume. But Chinese policy discourse increasingly shifted toward “high-value patents,” transfers, licensing, and industrialisation. Official CNIPA material now places significant emphasis on commercialisation and technology transaction outcomes. China recognised that a mountain of low-value patents may create statistical bravado, but not technological power. India today appears to be lingering in the very stage China has been trying to move beyond.
Against this comparative backdrop, India’s weaknesses become painfully clear. The first weakness is poor upstream filtering. Many institutions appear to file before conducting rigorous prior-art searches, novelty assessments, or commercial potential reviews. The second is weak prosecution quality. Even where an idea has some merit, badly drafted claims, poor disclosure, and inadequate response to examination objections can sink the application. The third is institutional immaturity. Technology transfer offices in India are often under-resourced, thinly staffed, or little more than ceremonial cells. The fourth is a weak commercialisation culture. Faculty members are usually rewarded for academic outputs or filing events, not for patiently moving a technology toward adoption. The fifth is industrial disconnect. Many university patents emerge from academic settings with little dialogue with actual manufacturers, service providers, or market users. The sixth is funding fragility. Proof-of-concept work, prototyping, validation, and scale-up require money, and India remains thin in these transition funds. The seventh is legal uncertainty and enforcement cost. A patent that cannot be confidently defended or monetised is less attractive to private industry.
Also Read: LPG Shortage Risk Grows as Strait of Hormuz Crisis Threatens India
This is why India fares badly not merely in grant rates, but also in the more consequential matter of innovation conversion. The country is producing a swelling tide of applications, but there is still little sign that university-origin IP is becoming a powerful engine of industrial or startup growth at scale. That is the uncomfortable truth hiding behind the filing boom. The problem is not simply that many private universities are filing weak patents. The problem is that the entire national conversation is still too mesmerised by filing data to ask what happens next.
From Patent Counts to Real Innovation: What India Must Fix
A sensible reform agenda must therefore begin by ending the worship of filing numbers. If NIRF and allied evaluation frameworks continue to attach meaningful rewards to published patents, they will continue to tempt institutions into filing for optics. The weighting system must be radically recalibrated so that granted patents, licensed technologies, patents actually commercialised, startups formed from institutional IP, and technology transfer income matter far more than patents simply published. If an institution files 1,000 applications and secures almost no grants, that should not be treated as a badge of innovation. It should trigger questions.
Transparency is equally critical. Every university that claims innovation leadership should be required to disclose, in a standardised public format, how many patents it filed, how many were published, how many were examined, how many received first examination reports, how many were abandoned, how many were refused, how many were granted, how many were opposed, how many were licensed, how many generated revenue, and how many resulted in startup formation or industrial deployment. Only then can Parliament, parents, policymakers, and the public distinguish between meaningful inventive activity and patent theatre.
India also needs a national technology transfer architecture, not just a patent encouragement architecture. Universities cannot be expected to commercialise inventions on goodwill and annual speeches. They need professionally run technology transfer offices, shared regional support structures for smaller institutions, proof-of-concept funds, legal and licensing expertise, incubator linkages, and sector-specific commercialisation networks. They need people who understand how to move from invention disclosure to market contact, from lab validation to prototype, from prototype to pilot, and from pilot to license or spin-off. Without this machinery, India will continue producing patents that impress ranking tables but rarely enter the bloodstream of the real economy.
The debate on misuse of public support also requires sharper policy design. Fee reductions for educational institutions need not be withdrawn; they serve a legitimate purpose. But larger incentives, reimbursements, or grant-linked recognitions should be tied increasingly to outcomes beyond filing. A staggered support model would make more sense: modest support at filing, stronger support for applications that survive examination, and far greater rewards for patents that are granted, licensed, or demonstrably commercialised. Such a model would reduce the incentive to flood the system with weak applications while still protecting genuine inventors from cost barriers.
Ultimately, India must decide whether it wants a patent culture or an innovation culture. The two are not the same. A patent culture counts applications, celebrates publication, and fills annual reports with impressive statistics. An innovation culture is harsher, slower, and more demanding. It asks whether the invention was truly novel. It asks whether the claims survived scrutiny. It asks whether a firm licensed it. It asks whether a startup was born from it. It asks whether the invention reached people, markets, hospitals, farms, factories, or public systems. It asks whether value was actually created.
That is the question private universities in India now force us to confront. Their filing boom has not merely raised eyebrows. It has exposed the fragility of our metrics, the softness of our incentives, and the hollowness of too much institutional boasting. The problem is not that private universities are active. Activity is welcome. The problem is that India has too often confused motion with progress. Filing is motion. Grant is validation. Commercialisation is impact. And impact, not paperwork, is the real test of innovation.
If India continues on the present path, it may soon become a world champion in generating patent statistics and a mediocre performer in generating patent value. That would be a tragic outcome for a country that genuinely has scientific talent, entrepreneurial energy, and a pressing developmental need for applied innovation. But if the present controversy triggers reform—if it forces a shift from quantity to quality, from filing to transfer, from publication to monetisation—then this moment of embarrassment may yet become a moment of institutional maturity. The choice is stark. India can keep applauding patent fireworks, or it can start building an innovation economy that actually burns bright.
The way forward lies not in scorning patents, but in restoring seriousness to them. India must stop rewarding universities merely for adding to the pile of published applications and begin rewarding them for producing patents that survive scrutiny and create value.
Ranking systems should sharply privilege granted and commercialised patents over published ones. Universities must be required to disclose patent lifecycle and commercialisation outcomes in a transparent, auditable format. Public support should move from filing-based encouragement to milestone-based support tied to examination survival, grant, licensing, and transfer.
Dedicated technology transfer capacity must be built, particularly for institutions that lack the size to create robust in-house offices.
Proof-of-concept financing, translational research support, and university-industry matchmaking should become national priorities. Most importantly, India must begin judging university innovation not by how many patent applications were pushed into the portal, but by how many ideas actually crossed the distance from paper to production. Only then will the country move from patent fever to genuine innovation strength.
Support Independent Journalism Public interest stories that affect ordinary citizens — especially those without power or voice — requires time, resources, and independence. Your support — even a modest contribution — allows us to uncover stories that would otherwise remain hidden. Support The Probe by contributing to projects that resonate with you (Click Here), or Become a Member of The Probe to stand with us (Click Here). |
Patent filings in India are soaring, especially in private universities, but low grant rates reveal a hollow “innovation boom” built on volume, not value.
P. Sesh Kumar is a retired 1982-batch officer of the Indian Audit and Accounts Service (IA&AS) who served under the Comptroller and Auditor General of India. Over a distinguished career, he contributed extensively to public sector auditing, financial oversight, and governance reforms across multiple sectors of government. He is the author of several books on public accountability and institutional governance, including CAG: Ensuring Accountability Amidst Controversies—An Inside View and CAG: What It Ought to Be Auditing. His later works broaden the canvas to issues such as financial accountability, India’s MSME and startup ecosystem, medical education reforms, and spiritual reflections on music and Nada Brahma.

